Layer 1

Pain rose during COVID-19 lockdown, Nurofen survey says


Backache, headache and joint pain rose among patients during lockdown, a survey commissioned by Nurofen has found.

The survey revealed that 36% of respondents reported increased backaches since the beginning of lockdown, out of the 2,000 responses that RWB gathered between July 31 and August 3 from people who experienced pain during lockdown.

The survey also indicated that fewer patients were able to speak to their pharmacist after lockdown was imposed, with 17% of respondents saying this, although the figure is five percentage points lower than that for GPs. 

The findings also revealed that 34% of respondents suffered more headaches, followed by 27% who flagged worsened joint pains, while 26% had more neck aches and 24% noted more muscle aches.

Some 60% of respondents wanted more advice on how to manage pain, the survey showed.

For more information on Nurofen products, visit the brand’s website

Have you dispensed many painkillers since the beginning of lockdown?
Login or register to post comments

Job of the week

General Practice Pharmacist
Armagh, Dungannon, Newry
Up to £40,894